Orthofix International | OFIX - Operating Profit

Stock Price
12.59
Daily Change
-0.28 -2.18%
Monthly
-1.64%
Yearly
-25.06%
Q1 Forecast
13.12

Orthofix International reported $-84.62M in Operating Profit for its fiscal quarter ending in December of 2024.





Operating Profit Change Date
Accuray USD 4.71M 6.86M Dec/2024
AngioDynamics USD -9.97M 1.12M Feb/2025
Artivion USD 4.39M 2.12M Sep/2024
AtriCure USD 2.49M 2.28M Dec/2025
Dexcom USD 323M 80.5M Dec/2025
EDAP TMS EUR -4.92M 843K Sep/2025
Globus Medical USD 181.31M 298.83M Dec/2025
Hologic USD 237M 16M Dec/2025
Inogen USD -7.79M 728K Sep/2024
Insulet USD 146.3M 28.6M Dec/2025
Integra LifeSciences USD 66M 54.24M Dec/2025
J&J USD 5.59B 1.81B Dec/2025
Medtronic USD 1.74B 40M Dec/2025
Mesa Laboratories USD 5.78M 2.27M Dec/2024
Orthofix International USD -84.62M 65.72M Dec/2024
Smith & Nephew USD 440M 50M Dec/2025
STAAR Surgical USD -10.93M 29.42M Dec/2025
Stryker USD 1.97B 609M Dec/2025
Surmodics USD -5.64M 276K Sep/2024
Tandem Diabetes Care USD 8.29M 31.16M Dec/2025
Teleflex USD 36.34M 445.24M Dec/2025
Veracyte USD 24.63M 1.52M Dec/2025
Zimmer Biomet Holdings USD 302.9M 35.4M Dec/2025